Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Belgium
Belgium: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage was 94.0% in 2024. ▬ Flat
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Belgium, 2012–2024
Source: WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data. Measured in %.
Analysis
Belgium recorded 94.0% for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in 2024. That is the highest value across all 13 years on record.
Compared with earlier readings it is up 1.1% over ten years.
Over the whole period, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Belgium peaked at 94.0% in 2015 and was at its lowest, 93.0%, in 2012.
That places Belgium 34th out of 146 countries with data for 2024, putting it in the top quarter.
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Belgium, year by year
| Year | % | Change |
|---|---|---|
| 2012 | 93.0% | — |
| 2013 | 93.0% | +0.0% |
| 2014 | 93.0% | +0.0% |
| 2015 | 94.0% | +1.1% |
| 2016 | 94.0% | +0.0% |
| 2017 | 94.0% | +0.0% |
| 2018 | 94.0% | +0.0% |
| 2019 | 94.0% | +0.0% |
| 2020 | 94.0% | +0.0% |
| 2021 | 94.0% | +0.0% |
| 2022 | 94.0% | +0.0% |
| 2023 | 94.0% | +0.0% |
| 2024 | 94.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 93.6% | 93.0% | 94.0% | 8 |
| 2020s | 94.0% | 94.0% | 94.0% | 5 |
Countries ranked near Belgium
More health data for Belgium
- Un projection of annual infant deaths, annual growth rate -3.28 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2923 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,160 deaths per 1,000 people (2090)
- Number of infants who die before age 1 59 deaths (2100)
- Population ages 0-14, female, annual growth rate -1.14 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.0768 units per person (2025)
- Population ages 0-14, male, annual growth rate -1.13 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.0803 units per person (2025)
Frequently asked questions
- What is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Belgium?
- Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Belgium was 94.0% in 2024, according to WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data.
- What is the highest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Belgium?
- The highest recorded value was 94.0% in 2015.
- What is the lowest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Belgium?
- The lowest recorded value was 93.0% in 2012.
- How does Belgium rank for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Belgium ranks 34th out of 146 countries with data for 2024.
- Is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage rising or falling in Belgium?
- Over the last ten years it is up 1.1%. The long-run trend across the full record is flat.
- Where does this Belgium data come from?
- The figures come from WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as part of Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 13 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.